Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography,  and the nuclear imaging modalities of PET and SPECT. 

Endocyte presents new biomarkers and fourth quarter loss

West Lafayette, Ind.-based biopharmaceutical company Endocyte announced Feb. 24 that the company's folate-receptor biomarkers vintafolide and etarfolatide had orphan drug status and were moving closer to approval with a review by the European Committee for Medicinal Products for Human Use (CHMP).

Thumbnail

NeuraCeq gets European approval for amyloid PET imaging

Piramal Imaging announced today that F-18 florbetaben, also known as NeuraCeq, is cleared for commercial marketing by the European Commission.

WMIC 2014 in Seoul is seeking abstracts

Not for another several months, the 2014 World Molecular Imaging Congress (WMIC) is scheduled to take Seoul, Korea, by storm from Sept. 17-20, but this week the Scientific Program Committee has made a formal request for abstracts to be submitted for presentation.

Thumbnail

Upcoming ECR 2014 in Vienna ramps up radiogenomics

The European Congress of Radiology (ECR) in Vienna, the largest radiological conference throughout Europe, will be opening in less than two weeks from March 6-10 at the Austria Center Vienna, where it has now been held for 20 consecutive years.

ADA Medical moves into preclinical research

The Toronto-based research group ADA Medical announced Feb. 14 that it would be collaborating with Ephoran Multi-Imaging Solutions in Turin, Italy, to provide preclinical imaging services.

Cancer disparity gets a closer look

Major cancer research organizations are banding together to assess how cancer disparity research will move forward. In the first collaboration of its kind, the American Association for Cancer Research (AACR) announced Feb. 13 that the institute would be working with the American Cancer Society, the American Society of Clinical Oncology (ASCO) and the National Cancer Institute (NCI) to address concerns such as access to health care and factors related to variability of cancer outcomes.

Thumbnail

RNA-enabled nanoparticles could treat liver disease

Massachusetts Institute of Technology engineers have fashioned a smarter nanoparticle that runs RNA interference as a means of disease modification, the institute announced Feb. 10.

Microfluidics could map how nanoparticles interact with atherosclerosis

The use of an endothelialized microfluidic chip could be the key to understanding how nanoparticles in biomedicine behave in the presence of atherosclerosis, according to a study published online Jan. 6 in the Proceedings of the National Academy of Sciences.